Partner Content
Partner Content
Applying a payer lens to your early pipeline planning
Understanding commercial and market access risks and opportunities at an early stage in biopharmaceutical product development is essential for optimizing commercial success.
![[Image (From top left to bottom right): Avalere’s leadership team, including Kelly Brantley, Policy Practice Director; Sarah Alwardt, Healthcare Transformation Practice Director; Elizabeth Carpenter, President; Lance Grady, Market Access Practice Director; Miryam Frieder, Policy Practice Director; Rob Carter, Financial Services Practice Director.]](https://pharmaphorum.com/wp-content/uploads/2022/06/Pinehurst-PR-2.jpg)
